Advancing Cancer Care for Dogs
Transforming canine cancer treatment through personalized medicine.
Transforming canine
cancer treatment
through
personalized medicine.
Transforming canine
cancer treatment
through personalized medicine.
There’s no “one-size-fits-all” treatment for cancer. That’s why FidoCure® uses genomic testing to determine the best course of action for your dog’s cancer therapy – beyond standard chemo and radiation.
FidoCure® Approach: Genetic testing reveals which targeted therapies may work best for your dog
Precision medicine can offer a hopeful prognosis. FidoCure® was created by dog lovers and scientists on a mission to make effective canine cancer treatment accessible. Our process uses genomic testing in conjunction with tumor type to identify possible cancer-causing mutations. From there, we suggest targeted therapy to precisely attack the cancer cells.
Forrest was diagnosed with splenic cancer and given one month to live.
Through the targeted therapy suggested by FidoCure®, he lived happily for nearly 4 years past his diagnosis.
Forrest, Golden Retriever
Hemophagocytic Histiocytic Sarcoma
Trusted by the Leading Veterinary Oncologists
Thousands of dogs have benefitted from FidoCure® when other options were limited.
Toulouse
“Since starting treatment, Toulouse’s tumors have regressed. FidoCure® brought us hope for Toulouse when we thought we didn’t have any options left.” — Daniel, FL
Lizzie
“Thanks to FidoCure®, Lizzie is 100% active again, eating well, and in remission for 5 months.” — Kimberley and Francois, CT
Gracie
“[Our vet] told us about the One Health Company’s precision medicine solution, FidoCure®… Now, exactly two months later, Gracie’s cancer is in remission.” — The Gonzalez Family, FL
Resources & Education
-
World Vet Day: Hear from Pet Parents
by FidoCure
On World Vet Day, we wanted to express our heartfelt gratitude to all our veterinarians and vet techs who work with our dogs. In […]
-
Adenocarcinoma Pet Parent Testimonial: Sammy
by FidoCure
At the heart of veterinary science lies a deep compassion for the well-being of our beloved animal companions. This is where FidoCure can […]
-
Dr. Fabian Kausche Joins FidoCure Advisory Board
by Christina K. Lopes
Leading Animal Health Expert Dr. Fabian Kausche Joins FidoCure Advisory Board
-
Celebrating 5 Years of Research at AACR
by Dr. Lucas Rodrigues in Vet
FidoCure by the One Health Company and Stanford University Research Shared at AACR 2024
-
Interview with Renowned Oncologist and Former FDA Leader Amy Abernethy
by Christina K. Lopes in Vet
-
Top Downloaded Cancer Paper in 2023
by Christina K. Lopes in Vet, Press
Our study in Nature's Scientific Reports was the 17th most downloaded cancer paper in 2023!
As Seen On
